ILMN
Illumina
Earnings and EPS analysis
- Stocks
- Healthcare
- NASDAQ: ILMN
- Earnings
EPS in 2026 (TTM): $5.4
Last Report Period Date: Jun 28, 2026
As of August 2026, according to Illumina's latest financial report, the company's current EPS (TTM) is $5.4. In 2025, the company recorded an earnings per share (EPS) of $5.47, which represents an increase compared to its EPS of -$7.69 in 2024. Illumina's earnings per share for the quarterly report ending on Jun 28, 2026 was $1.37.
ILMN earnings history
The annual EPS in 2025 was $5.47, an increase of 171.1% from -$7.69 in 2024. For the quarter ending Jun 28, 2026, the EPS was $1.37, showing a 8.1% decrease from the same quarter last year. The trailing twelve months (TTM) EPS as of June 2026 is $5.4. In 2024, the annual EPS was -$7.69, showing a decrease of 4.8% from 2023.
ILMN earnings chart
ILMN EPS growth history
Over the last 12 months, Illumina has registered an EPS growth of -8.1% (YoY, quarterly). Over the last 5 years, the company had an average EPS growth rate of 4.1%. When measured over a ten-year period, ILMN's average EPS growth rate was 5.5%.
ILMN Earnings Waterfall
ILMN Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| DGX Quest Diagnostics Inc | 24.32 | 14% | 3.1% | -3.5% |
| A Agilent Technologies Inc | 27.96 | 3.4% | 3.1% | 14.5% |
| TMO Thermo Fisher Scientific Inc | 31.14 | 7.2% | 0% | 2% |
| DHR Danaher Corp | 35.1 | -4.9% | -19.7% | 0.4% |
| ILMN Illumina Inc | 37.3 | 171.1% | N/A | 4.1% |
| PACB Pacific Biosciences of California Inc | N/A | -61.1% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.